Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00197704 · ClinicalTrials.gov registry record · Phase 3
Nutrition, Immunology and Epidemiology of Tuberculosis
A Phase 3 study of Tuberculosis, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- Phase 3
- Development phase
- 876
- Enrollment target
- 1
- Study location
NCT00197704: Completed Phase 3 study of Tuberculosis, sponsored by Harvard School of Public Health (HSPH).
NCT00197704 is a Phase 3 study of Tuberculosis that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 876 participants, roughly in line with the 904-participant average among 29 other Tuberculosis trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00197704, a Phase 3 study of Tuberculosis, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 876 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the efficacy of micronutrient supplementation among patients with active tuberculosis, half of who are co-infected with HIV-1
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Multivitamins
Study Locations (1)
Massachusetts
- Harvard School of Public Health - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 876 participants |
| Start Date | 2000-03 |
| Est. Completion | 2004-05 |
| Phase | Phase 3 |
What the finished NCT00197704 record still lists
NCT00197704 is an interventional study that assigns participants to a tested intervention. The registered 876 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 904-participant average among 29 other Tuberculosis trials with a reported enrollment target.
The record links to 1 condition, with Tuberculosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00197704 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00197704 about?
NCT00197704 is a clinical study titled "Nutrition, Immunology and Epidemiology of Tuberculosis". The purpose of this study is to determine the efficacy of micronutrient supplementation among patients with active tuberculosis, half of who are co-infected with HIV-1
What is the current status of trial NCT00197704?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 876 participants. The study started on 2000-03. Estimated completion is 2004-05.
What conditions does trial NCT00197704 study?
This clinical trial studies the following conditions: Tuberculosis.
What interventions are being tested in trial NCT00197704?
The interventions under investigation include: Placebo (OTHER), Multivitamins (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00197704?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00197704 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tuberculosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00197704's enrollment target sits among peer trials
876 3rd of 29 higher than 27 of 29 other Tuberculosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tuberculosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Training Protocol on the Natural History of Tuberculosis
RECRUITING
-
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
RECRUITING
-
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
ACTIVE NOT RECRUITING
-
Gene Expression in HIV and Tuberculosis Co-infection
COMPLETED
-
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
COMPLETED · Phase 1
-
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- NCT06627647 · 878 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia